<div>Paul Abrams, MBA, director of Health Care Specialty Group at MJH Life Sciences, speaks with Vaibhav Singh, co-founder and CEO of Circle of Life, about his company’s product, Zevac, which aims to help clinicians make more informed prescribing decisions. 
 
For a full transcript visit <a href="https://www.contagionlive.com/">https://www.contagionlive.com/</a>.</div>

Paul Abrams, MBA, director of Health Care Specialty Group at MJH Life Sciences, speaks with Vaibhav Singh, co-founder and CEO of Circle of Life, about his company’s product, Zevac, which aims to help clinicians make more informed prescribing decisions. For a full transcript visit https://www.contagionlive.com/.

Paul Abrams, MBA, director of Health Care Specialty Group at MJH Life Sciences, speaks with Vaibhav Singh, co-founder and CEO of Circle of Life, about his company’s product, Zevac, which aims to help clinicians make more informed prescribing decisions. 
 
For a full transcript visit&nbsp;<a href="https://www.contagionlive.com/" rel="noopener noreferrer">https://www.contagionlive.com/</a>.

S1 Ep3: Can Artificial Intelligence Play a Role in the Fight Against Antimicrobial Resistance?

<div>
Contagion® Community delves into some of the social factors that create and widen healthcare disparities. 
 
 
In surveying our audience, 75% of respondents viewed healthy equity as a major issue within medicine. Infectious disease often disproportionately occurs along the lines of ethnicity, race, class, education, sexual orientation, geographic location, and more. The entwined nature of healthcare inequity and social factors inhibits us from examining infectious disease objectively, which is why Contagion Community spotlights underserved populations. 
 
Through interviews with experts, we will offer insights into the issues associated with healthcare inequities and examine which strategies and solutions are being deployed to overcome these issues.  
 
Contagion Community is a marriage of major conversations occurring in hospitals, labs, academics, and communities.</div>

Science

Social Sciences

Life Sciences

Contagion® Community delves into some of the social factors that create and widen healthcare disparities. In surveying our audience, 75% of respondents viewed healthy equity as a major issue within medicine. Infectious disease often disproportionately occurs along the lines of ethnicity, race, class, education, sexual orientation, geographic location, and more. The entwined nature of healthcare inequity and social factors inhibits us from examining infectious disease objectively, which is why Contagion Community spotlights underserved populations. Through interviews with experts, we will offer insights into the issues associated with healthcare inequities and examine which strategies and solutions are being deployed to overcome these issues. Contagion Community is a marriage of major conversations occurring in hospitals, labs, academics, and communities.

Contagion® Community delves into some of the social factors that create and widen healthcare disparities. 
 
 
In surveying our audience, 75% of respondents viewed healthy equity as a major issue within medicine. Infectious disease often disproportionately occurs along the lines of ethnicity, race, class, education, sexual orientation, geographic location, and more. The entwined nature of healthcare inequity and social factors inhibits us from examining infectious disease objectively, which is why Contagion Community spotlights underserved populations. 
 
Through interviews with experts, we will offer insights into the issues associated with healthcare inequities and examine which strategies and solutions are being deployed to overcome these issues.&nbsp; 
 
Contagion Community is a marriage of major conversations occurring in hospitals, labs, academics, and communities.

Share S1 Ep3: Can Artificial Intelligence Play a Role in the Fight Against Antimicrobial Resistance?

Sign up to save your podcasts

S1 Ep3: Can Artificial Intelligence Play a Role in the Fight Against Antimicrobial Resistance?

S1 Ep3: Can Artificial Intelligence Play a Role in the Fight Against Antimicrobial Resistance?